Search

Author/Creator Jones, Jeffrey A.

22. Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Issue 4 (3rd April 2018)

Authors:
Andritsos, Leslie A.; Grieselhuber, Nicole R.; Anghelina, Mirela; Rogers, Kerry A.; Roychowdhury, Sameek; Reeser, Julie W.; Timmers, Cynthia D.; Freud, Aharon G.; Blachly, James S.; Lucas, David M.; Lozanski, Gerard; Jones, Jeffrey A.; Williams, Katie; Oakes, Christopher; Jones, Dan; Grever, Mich...
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 4(2018)
Page Start:
1008
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib. (10th April 2017)

Authors:
Jones, Jeffrey A.; Hillmen, Peter; Coutre, Steven; Tam, Constantine; Furman, Richard R.; Barr, Paul M.; Schuster, Stephen J.; Kipps, Thomas J.; Flinn, Ian W.; Jaeger, Ulrich; Burger, Jan A.; Cheng, Mei; Ninomoto, Joi; James, Danelle F.; Byrd, John C.; O'Brien, Susan M.
Journal:
British journal of haematology
Issue:
Volume 178:Number 2(2017)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗